Two doctors named BMS Korea’s medical directors

Published: 2007-07-09 06:52:00

Updated: 2007-07-09 06:52:00

Recently, BMS Korea appointed two doctors, Lee Young-sook and Chung Young-yeon, as medical director and medical advisor, respectively, to beef up its marketing activity of Baraclude (entecavir), an antiviral agent for treatment of chronic hepatitis B virus, which was launched in January.

A gra...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK